Glycemic Variability and Autonomic Nervous System in Cardiac Surgery Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

120 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-10-10

Study Completion Date

2024-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

On-pump coronary artery bypass graft (CABG) and valve replacement surgeries are high-risk procedures. Among the risk factors for postoperative complications, perioperative hyperglycemia and blood glucose variability have been reported to be associated with increased morbidity and mortality. The treatment of hyperglycemia using intravenous insulin infusion improves the prognosis in cardiac surgery patients. However, the determinants of postoperative blood glucose variability and the mechanisms leading to its deleterious impact are unknown. Thus, to date, there is no therapeutic intervention that could effectively prevent and treat the deleterious impact of glycemic variability on postoperative outcome. The purpose of the study is to evaluate whether perioperative alteration of the autonomic nervous system and preoperative blood glucose variability could be related to perioperative glycemic variability.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Perioperative Versus Postoperative Glycemia Control in Cardiac Surgery Patients

NCT01548963

Perioperative and Postoperative Hyperglycemia Tight Glycemia Control

COMPLETED NA

Improving Outcomes In Diabetic Patients During CABG Surgery By Optimizing Glycemic Control

NCT00460499

Glycemic Control

COMPLETED PHASE1

Outcomes Study of Hyperinsulinemic Glucose Control in Cardiac Surgery

NCT00524472

Cardiac Surgery

COMPLETED NA

Glucose Control in Open Heart Surgery

NCT00370643

Hyperglycaemia During Perioperative Period Heart Valve Diseases Ventricular Dysfunction

COMPLETED PHASE1

Intensive Insulin Therapy in Patients Undergoing Coronary Artery Bypass Surgery

NCT01361594

Diabetes

COMPLETED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The main objective is to describe the relationship between preoperative glycemic variability and glycemic variability during the first 48 postoperative hours.

The secondary objectives are :

1. to describe the relationship between preoperative glycemic variability and glycemic variability during the first 48 hours postoperative according to:

* diabetic and non-diabetic status
* the type of surgical intervention
2. to describe the relationship between the parameters evaluating the preoperative activity of the autonomic nervous system and:

* preoperative glycemic variability
* glycemic variability during the first 48 postoperative hours
3. to describe the relationship between glycemic variability during the first 48 postoperative hours and:

* parameters evaluating the activity of the autonomic nervous system during the first 48 postoperative hours
* diabetes phenotype
* markers of inflammation
* markers of endothelial dysfunction
4. to describe the morbidity and mortality within 30 days after surgery.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Blood Glucose Variability Cardiac Surgical Procedures Autonomic Nervous System

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Intervention Type PROCEDURE

aortic valve replacement surgery

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Planned cardiac surgery
* Age ≥ 18 years old and \< 80 years old
* Group 1: patients with known insulin-requiring type 2 diabetes mellitus undergoing planned on-pump coronary artery bypass surgery
* Group 2: patients with known non-insulin-requiring type 2 diabetes mellitus undergoing planned on-pump coronary artery bypass surgery
* Group 3: non-diabetic patients undergoing planned aortic valve replacement surgery
* Group 4: non-diabetic patients undergoing planned on-pump coronary artery bypass surgery

Exclusion Criteria

* Emergent surgery (less than 48 hours between anesthestetic consultation and surgery)
* Combined surgery (coronary artery bypass graft associated with valve surgery, multiple valve replacement, surgery of the ascending aorta)
* Extreme weight: body mass index (BMI) \> 35 kg.m-2 or \< 18 kg.m-2.
* Off-pump coronary artery bypass graft surgery
* Type 1 diabetes mellitus
* Patient unable to consent
* Pregnant and/or breastfeeding woman
* Permanent preoperative chronic heart rhythm disorder
* Pacemaker
* Unstable patient condition in preoperative period
* Expected life expectancy less than 48 hours.
* Subject unlikely to cooperate in the study and/or low cooperation anticipated by the investigator.
* Duration of continuous preoperative glycemic recording of less than 48 hours.

Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No